General Information of DTT (ID: TTCK85E)

DTT Name Immune costimulatory protein B7H4 (VTCN1) DTT Info
Gene Name VTCN1

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Clinical Trial Drug(s)
2 Clinical Trial Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
AZD8205 DMXKH0S Aggressive cancer 2A00-2F9Z Phase 2 [1]
PF-07260437 DMU7LYP Breast cancer 2C60-2C65 Phase 1 [2]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 Design and Preclinical Evaluation of a Novel B7-H4-Directed Antibody-Drug Conjugate, AZD8205, Alone and in Combination with the PARP1-Selective Inhibitor AZD5305. Clin Cancer Res. 2023 Mar 14;29(6):1086-1101.
2 ClinicalTrials.gov (NCT05067972) A PHASE 1 DOSE ESCALATION AND EXPANSION STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETIC, PHARMACODYNAMIC, AND ANTITUMOR ACTIVITY OF PF-07260437 IN ADVANCED OR METASTATIC SOLID TUMORS. U.S.National Institutes of Health.